This core finding—that Mfsd2a activation suppresses transcytosis—was directly replicated in a subarachnoid hemorrhage (SAH) model, where AAV‐mediated Mfsd2a overexpression protected the BBB via the same mechanism [42]. This evidence concerns the gene MFSD2A and subarachnoid hemorrhage.